The Balanced Opioid Initiative: Shared Decision-Making and Chronic Opioid Therapy
The Balanced Opioid Initiative focuses on opioid prescribing for patients with chronic, non-cancer pain. The overall course is designed to address the following for the health care team:
- Describe measures related to opioid prescribing
- Document your clinic's workflow related to refilling opioid prescriptions
- Identify a medium-term goal - one change that helps you reach the long-term goal
- Identify the first small change or changes you will make
- Evaluate progress; decide on the next small change(s)
- Continue making small changes until you reach the medium-term goal, and then repeat steps 4 to 6 with a new medium-term goal until you reach the overall goal
- Share what you have learned with others in the clinic
This activity is intended for physicians, physician assistants, nurses, and other interested health professionals.
ELEMENTS OF COMPETENCE
This activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of patient care and procedural skills, and medical knowledge. This activity also focuses on the interprofessional competency of teams/teamwork.
This is session 5 of 6 educational meetings. The Balanced Opioid Initiative: Shared Decision-Making and Chronic Opioid Therapy is designed to:
- Describe shared decision-making (SDM) and determine clinical scenarios where SDM would be an appropriate communication technique to use with people who have chronic pain
- Synthesize knowledge of risks and benefits of chronic opioid use with patient preferences and clinician safety priorities
- Welcome and Introductions
- Principles of Shared Decision Making
- Shared Decision-Making Techniques in the Context of Opioid Prescribing for Chronic Pain
- Case Study
- Next Steps
- Tuesday, June 15, 12:00-1:00 pm
- Thursday, June 17, 12:00-1:00 pm
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate, and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters, and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures can by found by clicking on the link below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be commercial interests.
|In support of improving patient care, the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
CREDIT DESIGNATION STATEMENTS
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.
Continuing Education Units (CEUs)
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for .1 CEU or 1 hour.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™